July 5, 2015 | Teva Pharmaceutical Industries and Philips Healthcare will reportedly invest up to $26.5 million in Israeli medical device and health innovation startups over the next eight years through their joint fund, Sanara Ventures. Sanara Ventures has already invested in two Israeli companies, Kaleidoscope Medical, which has developed a system to shield against X-ray radiation during catherterisation procedures, as well as MGD, which creates a portable device to measure lung function in patients with Chronic Obstructive Pulmonary Disease (COPD). Sanara Ventures was established this year and is headed by its Chief Executive Assaf Barnea.
Subscribe to NoCamels weekly newsletter and get our top stories
Related posts

AI Can Predict Future Heart Attacks By Analyzing CT Scans
October 01, 2023

Israeli Startups Create Powerful Drone-Detecting Software
September 28, 2023

Model Sees Daylight As Boost For Hospitalized Patients’ Health
September 28, 2023

Solar Panels On A Roll Certified As Safe For Use In US, Europe
September 28, 2023
Facebook comments